Media AffairsVerified account

@FDAMedia

Official twitter account of FDA's Office of Media Affairs. (301) 796-4540; fdaoma@fda.hhs.gov Privacy Policy -

Silver Spring, MD
fda.gov
Joined May 2014
76 Photos and videos Photos and videos

Tweets

You blocked @FDAMedia

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @FDAMedia

  1. Retweeted
    5 hours ago

    SAFETY ALERT: FDA is advising consumers, tattoo artists & retailers to avoid using/selling 6 recalled tattoo inks contaminated w/ bacteria that can cause infections & lead to serious health injuries when injected into the skin during a tattooing procedure.

    BERJAYA
    1 reply 30 retweets 9 likes
    Show this thread
    BERJAYA
    Show this thread
    Undo
  2. 23 hours ago

    Today, Acting Dr. Ned Sharpless spoke at a workshop on youth tobacco cessation and reiterated the agency’s commitment to ensuring all tobacco products, including e-cigarettes, aren’t being marketed to, sold to or used by kids:

    BERJAYA
    Undo
  3. Retweeted
    May 15

    Today I leave FDA with a full heart. It has been an honor to be a part of this agency and to work with such amazing, mission-driven and dedicated people. Team OMA, thanks for all you do! For those who followed me, follow FDA’s press office at for the latest from FDA

    BERJAYA
    3 replies 3 retweets 16 likes
    Undo
  4. 24 hours ago

    Today’s action is part of FDA’s broader effort to assure device safety; this includes ongoing actions to enhance post-market surveillance to identify & address new safety concerns once a device is on the market and to encourage innovations that lead to safer medical devices.

    1 like
    Show this thread
    BERJAYA
    Show this thread
    Undo
  5. 24 hours ago

    FDA provided important updates today on agency’s continued commitment to evaluating postmarket safety of Essure permanent birth control device. While device is no longer sold, FDA is committed to monitor its long-term safety profile.

    BERJAYA
    1 reply 3 retweets 3 likes
    Show this thread
    BERJAYA
    Show this thread
    Undo
  6. May 14

    Principal Deputy Commissioner in NYC today for US Pharma & Biotech Summit discussing patient-owned data in the context of FDA’s Real-World Evidence Framework and what innovation is needed to advance its goals.

    BERJAYA
    1 like
    Undo
  7. Retweeted
    May 14

    FDA’s Center for Veterinary Medicine will hold a public meeting on July 16, 2019, on alternative approaches in clinical investigations for new animal drugs. For more information & to register, see our CVM Update:

    BERJAYA
    1 reply 3 retweets 5 likes
    Undo
  8. May 14

    Immunization against measles not only protects children, it also protects other people who can’t be vaccinated, including infants and those with weakened immune systems caused by illness, such as people with cancer who receive chemotherapy.

    BERJAYA
    As of April 26, more than 70% of the 704 people with confirmed measles since January 1 were unvaccinated. On-time vaccination with two doses of MMR vaccine is the most effective way to limit the spread of measles virus. Read the recent :
    1 reply 46 retweets 67 likes
    Undo
  9. May 14

    The FDA plays a vital role in ensuring the safety and effectiveness of all vaccines licensed for use in the U.S., including those that prevent measles.

    4 retweets 6 likes
    Undo
  10. May 14

    The most effective way to prevent diseases like measles to is vaccinate against them. We remain confident in the safety and efficacy of the MMR vaccine.

    BERJAYA
    Vaccines are safe. They are tested with human volunteers for years before they are approved. If new ingredients are added, they are retested. Check out our website to learn more about vaccine safety:
    Undo
  11. May 13

    This report and the efforts of our pharmaceutical quality office aid in our public health mission to assure patients and consumers have access to safe, effective, quality medicines.

    Show this thread
    BERJAYA
    Show this thread
    Undo
  12. May 13

    Today, FDA is releasing a report of the drug industry’s capacity to deliver quality products using 10-year data from inspections, recalls, shortages & more. FDA’s drug quality staff uses this to inform regulatory decision-making & surveillance activities.

    1 reply 1 retweet 1 like
    Show this thread
    BERJAYA
    Show this thread
    Undo
  13. May 13

    FDA’s Office of Pharmaceutical Quality, formed in 2015, works to identify and respond to quality issues, no matter where they occur, before they become problems, & oversees drug quality throughout the product lifecycle, before and after approval.

    BERJAYA
    1 reply 1 like
    Show this thread
    BERJAYA
    Show this thread
    Undo
  14. May 13

    Reporters: for copies of presentations from today’s public hearing on biosimilar and interchangeable insulin products email, FDAOMA@fda.hhs.gov.

    Show this thread
    BERJAYA
    Show this thread
    Undo
  15. May 13

    ICYMI: Remarks given by at today’s public hearing on Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products are available online:

    1 reply
    Show this thread
    BERJAYA
    Show this thread
    Undo
  16. May 13

    FDA oversight also includes testing selected finished drug products after they’re on the market. FDA tested 323 generic drug products from foreign manufacturers, including more than 100 Indian generic drug products. All of the samples met U.S. market quality standards.

    BERJAYA
    Show this thread
    BERJAYA
    Show this thread
    Undo
  17. May 13

    In recent years, we’ve undertaken more rigorous review of generics than ever before. We’ve hired over 1,000 people to meet the workload demands of our robust generic program and our staff will continue advancing our efforts forward to protect U.S. public health.

    1 reply 1 retweet 1 like
    Show this thread
    BERJAYA
    Show this thread
    Undo
  18. May 13

    In our latest read how FDA’s review process for new generic drug applications ensures that generic medications perform the same way, have the same active ingredients, same conditions of use as the counterpart name brand medication.

    BERJAYA
    Undo
  19. May 13

    The FDA will continue to remain vigilant in its compliance and enforcement work and will build upon previous actions to protect public health and to make sure Americans have confidence in the quality of products sold in the U.S. regardless of where they are manufactured.

    3 likes
    Show this thread
    BERJAYA
    Show this thread
    Undo
  20. May 13

    The FDA does not believe that increased numbers of warning letters reflect a growing problem in drug quality, but rather the effectiveness of our focus on the facilities and drugs that have the potential to be the most problematic.

    1 reply 1 retweet 2 likes
    Show this thread
    BERJAYA
    Show this thread
    Undo

@FDAMedia hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·